MLH - Main Line Health Inc.

10/27/2021 | Press release | Distributed by Public on 10/27/2021 09:37

Lankenau Heart Group and Main Line HealthCare Primary Care earn national recognition for efforts to improve cardiovascular health for patients

October 27, 2021News Releases

The American Heart Association presents multiple awards for implementation of quality care for patients.

Lankenau Heart Group and Main Line HealthCare primary care physician practices, all part of Main Line Health, have been recognized by the American Heart Association (AHA) for their commitment to managing heart disease and stroke risk by controlling risk factors like high cholesterol, diabetes, and blood pressure. The three awards are a testament to the entire clinical team's commitment to the prevention, diagnosis, treatment and management of cardiovascular disease.

Nearly half of all adults in the U.S. have experienced some form of cardiovascular disease - including heart attack, stroke and heart failure. Leading risk factors for cardiovascular disease include high cholesterol, type 2 diabetes, and uncontrolled high blood pressure, but through proper risk factor diagnosis and treatment, heart disease and stroke can be prevented or managed.

"These well-deserved awards recognize Lankenau Heart Group and Main Line HealthCare primary care physician practices for their ongoing commitment to keeping our patients well by not only following proven guidelines that reduce the onset or recurrence of cardiovascular disease, but also by providing education and guidance to help inform healthy decisions. These awards are a testament to the high quality and excellent care being provided across our practices" said William Gray, MD, System Chief of Cardiovascular Disease at Main Line Health."

To improve quality of care and help people learn to manage their risk factors around high cholesterol, type 2 diabetes and/or blood pressure management, Lankenau Heat Group participates in the following programs and received achievement awards once again this year:

  • Check. Change. Control. Cholesterol™ Participant
  • Target: Type 2 Diabetes℠ Gold
  • Target: BP™ Gold recognition from both the American Heart Association and the American Medical Association (AMA)

"Both Lankenau Heart Group and Main Line HealthCare are honored to be recognized by the American Heart Association. We appreciate being acknowledged for our dedication to helping our patients have the resources to manage risk factors and hopefully reduce or avoid heart attacks, stroke and other preventable heart concerns," said Eric Mankin, MD, President, Main Line HealthCare. "Programs like the ones that address the real-world problems of high blood pressure, high cholesterol and uncontrolled type 2 diabetes are necessary to improve health today and avoid larger problems for many patients tomorrow."



About Lankenau Heart Institute

The Lankenau Heart Institute is Main Line Health's premier, comprehensive cardiovascular medicine and surgery program. The Lankenau Heart Institute brings together the clinical expertise of all four Main Line Health acute care hospitals and community cardiology practices to ensure that patients receive a level of quality, service, and experience that is unprecedented in the region. Through the system-wide coordination of services, the Lankenau Heart Institute delivers preventive, diagnostic, therapeutic, and rehabilitative cardiovascular services at each of our locations including Lankenau Medical Center, Bryn Mawr Hospital, Paoli Hospital and Riddle Hospital.

Lankenau Heart Institute continues to be a pioneer in the use of beating-heart techniques and robotic-assisted procedures for coronary artery revascularization, minimally invasive and transcatheter approaches for valve repair and replacement, and complex aortic surgeries. With our growing experience and focus on minimally invasive techniques, Lankenau Heart Institute has expanded participation in clinical trials year over year. Our physicians are frequently invited to participate in clinical/medical device trials, many of these designed to facilitate minimally invasive procedures/approaches.

With a collaborative team of expert consultative cardiologists, interventional cardiologists, electrophysiologists, cardiovascular surgeons and specially trained nurses and technologists, the Lankenau Heart Institute is dedicated to managing and treating patients with heart failure, aortic disease, coronary and peripheral vascular disease, heart rhythm disorders and valve disease. Our team of cardiologists and cardiac specialists provide patients and their families with expert cardiac care, close to home.



About Main Line Health

Founded in 1985,Main Line Health is a not-for-profit health system serving portions of Philadelphia and its western suburbs. Main Line Health's commitment-to deliver advanced medicine to treat and cure disease while also playing an important role in prevention and disease management as well as training physicians and other health care providers-reflects our intent to keep our community and ourselves well ahead. A team of more than 10,000 employees and 2,000 physicians care for patients throughout the Main Line Health system.

At Main Line Health's core are four of the region's most respected acute care hospitals-Lankenau Medical Center, Bryn Mawr Hospital, Paoli Hospital and Riddle Hospital-as well as one of the nation's recognized facilities for rehabilitative medicine, Bryn Mawr Rehabilitation Hospital.

Main Line Health also includes Mirmont Treatment Center for drug and alcohol recovery; Main Line Health HomeCare & Hospice, which includes skilled home health care, hospice and home infusion services; Main Line Health Centers, primary and specialty care, lab and radiology, and other outpatient services located in Broomall, Collegeville, Concordville, Exton, King of Prussia and Newtown Square; Lankenau Institute for Medical Research, a biomedical research organization; and Main Line HealthCare,one of the region's largest multispecialty physician networks.

Main Line Health is the recipient of numerous awards for quality care and service, including System Magnet® designation, the nation's highest distinction for nursing excellence and the Mid-Atlantic Alliance for Performance Excellence (MAAPE) Excellence Award. Main Line Health is committed to creating an environment of diversity, respect and inclusion and has proudly embraced the American Hospital Association's #123forEquity Pledge to Act to eliminate disparities in care. We are dedicated to advancing patient-centered care, education and research to help our community stay healthy.



About Target: BP™

Target: BP is a national collaboration between the AHA and the AMA aimed at reducing the number of Americans who suffer from heart attacks and strokes each year by urging physician practices, health systems and patients to prioritize BP control. The initiative aims to help health care organizations improve blood pressure control rates through use of AMA MAP BP™ evidence-based protocol, and recognizes organizations committed to improving blood pressure control.



About Check. Change. Control. Cholesterol™

The American Heart Association, the world's leading voluntary organization dedicated to building longer, healthier lives, created the Check. Change. Control. Cholesterol™ initiative with national support from Amgen to improve awareness, detection and management of high cholesterol for consumers, patients and health care professionals.



About Target: Type 2 Diabetes™

The American Heart Association, the world's leading voluntary organization dedicated to building longer, healthier lives, created the Target: Type 2 Diabetes™ initiative as a part of the Know Diabetes by Heart™ effort to raise awareness and understanding of the link between diabetes and cardiovascular disease among patients, caregivers and health care professionals as well as empower patients and care givers to better manage risk factors.

The Target: Type 2 Diabetes program supports physicians and care teams by offering access to the latest research, tools and resources to provide the latest cardiovascular and type 2 diabetes management and treatment guidelines.